Search Results - "Esdur, Pinar Coban"
-
1
A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR)
Published in BMC cancer (23-05-2024)“…Cervical cancer is a tumor with high morbidity and mortality. The importance of inflammatory and metabolic parameters affecting progression-free survival (PFS)…”
Get full text
Journal Article -
2
The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker
Published in Breast cancer targets and therapy (01-01-2024)“…Hormone positive breast cancer is a tumor with high mortality. Combining antihormonal therapy with cyclin dependent kinase 4/6 inhibitors (CDK4/6i) has…”
Get full text
Journal Article -
3
The Effect of C-Reactive Protein/Lymphocyte Ratio
Published in Breast cancer targets and therapy (31-07-2024)“…Objective: Hormone positive breast cancer is a tumor with high mortality. Combining antihormonal therapy with cyclin dependent kinase 4/6 inhibitors (CDK4/6i)…”
Get full text
Journal Article -
4
Inflammatory parameters in NSCLC with driver mutation
Published in Lung cancer management (2024)“…The tumor microenvironment of NSCLC with driver mutations, such as , and , is less inflammatory. This retrospective study included 38 patients with NSCLC…”
Get full text
Journal Article -
5
Tumor Lysis Syndrome Due to Pembrolizumab Use in Metastatic Nasopharyngeal Carcinoma
Published in Archives of Basic and Clinical Research (05-02-2024)Get full text
Journal Article